The Role of Surrogate Endpoints in the Evaluation of Efficacy and Safety of Therapeutic Interventions in Diabetes Mellitus

Aleksandra Wieczorek , Przemyslaw Rys ,Iwona Skrzekowska-Baran ,Maciej Malecki

Read More

The Current Status of Islet Transplantation and its Perspectives

Naoya Kobayashi

Read More

Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes

Mikael Maksimow, Catharina Alam, Arno Hänninen

Read More

Initiating or Switching to Biphasic Insulin Aspart 30/70 Therapy in Subjects with Type 2 Diabetes Mellitus. An Observational Study

Leif Breum ,Thomas Almdal ,Pia Eiken ,Per Lund ,Erik Christiansen

Read More

Effects of Gender and Height on the Oral Glucose Tolerance Test: The Isfahan Diabetes Prevention Study

Mohsen Janghorbani ,Massoud Amini

Read More

Tracing the Pathogenesis of Type 1 Diabetes: A Report on the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD)

Liang-Hao Guo, Peter Achenbach

Read More

All we need is GWAS: Genome-Wide Association Studies in Type 2 Diabetes Mellitus presented on the 2008 EASD Meeting in Rome

Tomasz Klupa, Maciej T. Malecki

Read More

Intensive Glycemic Control and Macrovascular Disease in Type 2 Diabetes – A Report on the 44th Annual EASD Meeting, Rome, Italy, September 2008

Tapani Rönnemaa

Read More

Anti-diabetic Agents in Type 2 Diabetes: A Review of New Data Presented and Discussed on the EASD meeting in Rome, 2008

Harold W. de Valk

Read More